deutetrabenazine

deutetrabenazine
Trade Name
Orphan Indication Tourette syndrome
USA Market Approval USA
USA Designation Date 2015-01-13 00:00:00
Sponsor TEVA Pharmaceuticals;3366 North Torrey Pines Court, Suite 225;LaJolla, California, 92037
Related Access Program
DEKK-TEC, Inc. – Document Safety for DM-CHOC-PEN in AYA Subjects With Advanced Cancer Eastern Regional Medical Center – Oncology Patients With Gastroparesis DEKK-TEC, Inc. – Document Safety for DM-CHOC-PEN in Pediatric and Adolescent Subjects With Advanced Cancer